News

MPR14h
FDA Clears Novel Wearable Defibrillator to Prevent Sudden Cardiac Arrest
The Food and Drug Administration (FDA) has cleared the Jewel ® Patch Wearable Cardioverter Defibrillator (Patch-WCD) for adult patients aged 18 years and older who are at risk for sudden cardiac ...
The Cardiology Advisor16h
The Benefits and Risks of ICD Therapy in Brugada Syndrome
Implantable cardioverter-defibrillator therapy in patients with Brugada syndrome is effective for prevention of fatal arrhythmias.
The Manila Times16h
HeartSciences Adds Prominent Key Advisors to its Scientific Advisory Board
HeartSciences Inc.(Nasdaq:HSCS) ("HeartSciences" or the "Company"), an artificial intelligence (AI)-powered medical technology comp ...